Hattori et al., 1987 - Google Patents
Anti-HTLV-III and anti-HTLV-I antibodies and T cell subsets in hemophiliacs living in HTLV-I endemic and nonendemic areas of JapanHattori et al., 1987
- Document ID
- 11803878227641393144
- Author
- Hattori T
- Ikematsu S
- Chosa T
- Yamamoto S
- Matsuoka M
- Fukutake K
- Robert-Guroff M
- Takatsuki K
- Publication year
- Publication venue
- Acta haematologica
External Links
Snippet
Sera from 154 hemophiliacs, including 132 with hemophilia A and 22 with hemophilia B, were examined for antibodies against human T cell lymphotropic virus type III (HTLV-III) and type I by strip radioimmunoassay based on the Western blotting technique. Sixty-two …
- 108090001123 antibodies 0 title abstract description 36
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—AIDS or HTLV
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/746—Erythropoetin
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Learmont et al. | Long-term symptomless HIV-1 infection in recipients of blood products from a single donor | |
Jackson et al. | Rapid and sensitive viral culture method for human immunodeficiency virus type 1 | |
JP2729212B2 (en) | HIV Purified and Isolated Retrovirus | |
Verdier et al. | Prevalence of antibody to human T cell leukemia virus type 1 (HTLV-I) in populations of Ivory Coast, West Africa | |
Melief et al. | Transmission of lymphotropic retroviruses (HTLV-I and LAV/HTLV-III) by blood transfusion and blood products | |
Couroucé et al. | Seroepidemiology of HTLV-I/II in universal screening of blood donations in France | |
FUKUSHIMA et al. | Extraordinary high rate of HTLV type II seropositivity in intravenous drug abusers in South Vietnam | |
Maul et al. | Simian retrovirus D serogroup 1 has a broad cellular tropism for lymphoid and nonlymphoid cells | |
Wiktor et al. | Human T cell lymphotropic virus type I (HTLV-I) among female prostitutes in Kinshasa, Zaire | |
Anderson et al. | Transfusion-acquired human immunodeficiency virus infection among immunocompromised persons | |
Wylie | Transfusion transmitted infection: viral and exotic diseases | |
LEDERMAN et al. | Acquisition of antibody to lymphadenopathy-associated virus in patients with classic hemophilia (factor VIII deficiency) | |
Tas et al. | A monocyte chemotaxis inhibiting factor in serum of HIV infected men shares epitopes with the HIV transmembrane protein gp41. | |
Kreiss et al. | Human T cell leukemia virus type III antibody, lymphadenopathy, and acquired immune deficiency syndrome in hemophiliac subjects. Results of a prospective study | |
Hattori et al. | Anti-HTLV-III and anti-HTLV-I antibodies and T cell subsets in hemophiliacs living in HTLV-I endemic and nonendemic areas of Japan | |
Robert-Guroff et al. | HTLV-III neutralizing antibody development in transfusion-dependent seropositive patients with beta-thalassemia. | |
Lee et al. | Human T‐cell leukemia virus type I infection in hemodialysis patients | |
Agostini et al. | Increased levels of soluble CD8 molecule in the serum of patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related disorders | |
Rappocciolo et al. | Association of alpha interferon production with natural killer cell lysis of U937 cells infected with human immunodeficiency virus | |
Gill et al. | HTLV-III serology in hemophilia: Relationship with immunologic abnormalities | |
Courouce et al. | HIV 2 infection among blood donors and other subjects in France | |
Arnow et al. | False-positive results of screening for antibodies to human immunodeficiency virus in chronic hemodialysis patients | |
Mittelman et al. | Analysis of T cell subsets in different clinical subgroups of patients with the acquired immune deficiency syndrome. Comparison with the “classic” form of Kaposi's sarcoma | |
McGrath et al. | Spectrum of HTLV‐III infection in a hemophilic cohort treated with blood products from a single manufacturer | |
Hoxie et al. | Relation of human T lymphotropic virus type III antibodies to T lymphocyte subset abnormalities in hemophiliac patients |